Boehringer wins time to oppose Intervet patent after lawyers botched deadline

FB Rice 2019-07-22 4:56 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

A unit of Boehringer Ingelheim has been given more time to oppose a proposed patent by rival drug maker Intervet, after the German drug company’s lawyers sent an email with the wrong opposition deadline.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au